Canadian Cancer Trials Group Bulletins


Recent Publication

Final results of Canadian Cancer Trials Group HD.6 -- Randomized Comparison of ABVD Chemotherapy with a Strategy that Includes Radiation Therapy in Patients with Limited-Stage Hodgkin's Lymphoma -- were published online in the New England Journal of Medicine and are featured in the recent edition of the NCI Bulletin.

These results show that patients with limited-stage Hodgkin's lymphoma treated with a standard chemotherapy regimen have better overall survival rates compared with those receiving a radiation-based treatment.

Patients with limited-stage Hodgkin's lymphoma (HL) are often treated with combination therapy containing chemotherapy plus radiation. While this therapy is successful in controlling HL, these patients remain challenged by potential long-term complications of radiation exposure such as heart conditions or subsequent cancers.

This trial was led by the Canadian Cancer Trials Group with participation of the Eastern Cooperative Oncology Group.

View the

Full Publication:



View the

Feature Article in the NCI Bulletin: